Kardium Inc.’s Post

What will you say when your boss asks:"How do the parts of your strategy fit together?" When she or he does, it's because they know that strategies only work when the parts synergise and they fail when their parts conflict. If you would like to give your boss a better answer to this question, listen to this podcast and, if you would like the article that it's based on, get in touch. https://lnkd.in/ewGqdXbr

Listen to the podcast of "Defining 'true acid reflux' after peroral endoscopic myotomy for achalasia: a prospective cohort study" by Singh and colleagues. https://lnkd.in/gDCD_cD 

What would you say if I asked you "What's the difference between your strategy and that of your competitors?" Usually when I ask this question, the answer goes no further than tactical details. Few strategies are strategically differentiated, which means they compete head on. Head on competition usually fails, especially if you're the smaller competitor. If you would like to give your boss a better answer to this question, listen to this podcast. And, if you repost this post with a commendation, I'll send you the published article on which it is based https://lnkd.in/evJ5Ycn5

🚨 NEW FEMTECH EPISODE 🚨 In this episode of the The FemTech Series Olivia Friett, editor of Medical Plastics News talks to Ikram Guerd, general manager & VP global marketing at Aspivix about the Carevix device - a suction cervical stabiliser, which is clinically proven to reduce pain and bleeding during transcervical procedures. You can listen to the full episode here: https://lnkd.in/eYJaZ4nk Or wherever you listen to your podcasts! #femtech #medtech #gynaecology

If you want to see elegant leadership at work, listen to this podcast. Kudos to Scott and Ivan for showing the way.

In this special edition of GT: The Podcast, I. Paul Singh, MD, invites Christine Funke, MD, and Pradeep Ramulu, MD, PhD, to talk about the Hydrus Microstent (Alcon), discussing data from the HORIZON trial as well as sharing real-world experiences with the MIGS device in their practices. They further explain how the data help one to decide and understand where the Hydrus fits into the glaucoma treatment paradigm, and they also share insertion pearls for the procedure to achieve successful microstent placement. Listen to the full podcast here: https://bit.ly/3SFv89H

🧬 Advanced therapies could transform patient outcomes – but improving access requires us to overcome the barriers to scaling in CGT manufacturing. Jason C. Foster, Ori Biotech’s CEO, recently spoke to Anshul Mangal, President at Project Farma (PF), about the critical importance of process, throughput, failure rates, and cost in the CGT manufacturing. Until these are solved, we will continue to see challenges to viability of our industry. We are committed to empowering scientists with flexible tools that streamline development to scale the impact of life-changing therapies. Our IRO® platform aims to address these barriers to viability directly: by automating and scaling CGT manufacturing, increasing efficiency, and reducing the costs of therapy development. This ensures that advanced therapies are not only widely available to patients but affordable, too. Listen to Anshul's episode of the Ori Spotlight Podcast: 🎧 Spotify: https://lnkd.in/efD6iM79 📺 Youtube: https://lnkd.in/eWtHtexx #IRO #TheNewStandard #AutomateBetterBiology #AccelerateProductDevelopment #ScaleYourImpact

Releasing Soon! 🎙️ New podcast episode with Lior Shaltiel, PhD and Nisim Perets, discussing the significance of the groundbreaking exosome loading method detailed in our latest patent application. Stay tuned for insights at the intersection of science and innovation! #PodcastRelease #ExosomeLoading #InnovationJourney

Empowering Patients and Transforming Healthcare: The MyRxWallet Revolution In today’s digital healthcare ecosystem, patient data is one of the most valuable assets, yet the question remains—who benefits from it? At MyRxWallet, we firmly believe that patients should be in control of their data and reap the rewards of its monetization. It’s their health, their information, and it should be their choice. Through MyRxWallet’s blockchain-powered platform, we provide patients the opportunity to securely monetize their anonymized data, whether for research, drug discovery, or healthcare innovation. But we take it a step further. Additionally, MyRxWallet’s robust Blockchain EHR, coupled with AI-driven healthcare technology, offers healthcare professionals a comprehensive patient summary, complete with diagnostic tips based on current health issues, lab results, X-rays, and imaging. Our AI helps tailor treatment plans, including referrals to specialists, recommended medical devices, lab work, and imaging—all of which align with the patient’s insurance coverage. For each treatment or referral recommendation, our EHR populates a list of providers covered by the patient’s insurance and, when prior authorization is required, our system automatically packages the necessary documentation, ensuring a painless, expedited approval process. By adhering to industry best practices and payer-specific guidelines, we facilitate faster solutions and reimbursements for both patients and providers. At MyRxWallet, we’re not just creating technology; we’re building a future where patients are empowered to control and benefit from their data, while healthcare professionals are equipped with cutting-edge tools to deliver precise and effective care. Together, we can revolutionize the healthcare industry. #Blockchain #EHR #AIHealthcare #PatientData #DataMonetization #HealthcareInnovation #InsuranceOptimization #MyRxWallet #Web3

Curious about the future of nerve repair? Hear Brandon Mark from BioCircuit Technologies discuss Nerve Tape on the Next Level Idea podcast with Eric I Anderson. Check it out! 🎙️ #nervetape #biocircuit #nerverepair #medicaldevice #medicalinnovation